PINK1 and Ataxin-2 as modifiers of growth
- A recent report showed PINK1 transcript levels to be up- or down-regulated by the gain or loss of Ataxin-2 function, respectively, in human blood, in a human neural cell line and in mouse tissues. These observations may have profound implications for the regulation of cell growth and may be medically exploited for the treatment of cancer and neural atrophy...
Author: | Nesli Ece ŞenGND, Suzana Gispert, Georg AuburgerORCiDGND |
---|---|
URN: | urn:nbn:de:hebis:30:3-441221 |
DOI: | https://doi.org/10.18632/oncotarget.16636 |
ISSN: | 1949-2553 |
Pubmed Id: | https://pubmed.ncbi.nlm.nih.gov/28430647 |
Parent Title (English): | OncoTarget |
Publisher: | Impact Journals LLC |
Place of publication: | [s. l.] |
Document Type: | Article |
Language: | English |
Date of Publication (online): | 2017/05/22 |
Date of first Publication: | 2017/03/28 |
Publishing Institution: | Universitätsbibliothek Johann Christian Senckenberg |
Release Date: | 2017/05/22 |
Tag: | motor neuron disease; neuroblastoma regression; obesity; tumor suppressor |
Volume: | 8 |
Issue: | 20 |
Page Number: | 2 |
First Page: | 32382 |
Last Page: | 32383 |
Note: | All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License. |
HeBIS-PPN: | 421385154 |
Institutes: | Medizin / Medizin |
Dewey Decimal Classification: | 6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit |
Sammlungen: | Universitätspublikationen |
Licence (German): | Creative Commons - Namensnennung 3.0 |